File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: NICE guidance: why not clozapine for treatment-refractory bipolar disorder?

TitleNICE guidance: why not clozapine for treatment-refractory bipolar disorder?
Authors
Bastiampillai, TGupta, AAllison, SChan, KW
Issue Date2016
Citation
The Lancet Psychiatry, 2016, v. 3, p. 502-503 How to Cite?
DOI: http://dx.doi.org/10.1016/S2215-0366(16)30081-5
Persistent Identifierhttp://hdl.handle.net/10722/254745

 

DC FieldValueLanguage
dc.contributor.authorBastiampillai, T-
dc.contributor.authorGupta, A-
dc.contributor.authorAllison, S-
dc.contributor.authorChan, KW-
dc.date.accessioned2018-06-21T01:05:52Z-
dc.date.available2018-06-21T01:05:52Z-
dc.date.issued2016-
dc.identifier.citationThe Lancet Psychiatry, 2016, v. 3, p. 502-503-
dc.identifier.urihttp://hdl.handle.net/10722/254745-
dc.languageeng-
dc.relation.ispartofThe Lancet Psychiatry-
dc.titleNICE guidance: why not clozapine for treatment-refractory bipolar disorder?-
dc.typeArticle-
dc.identifier.emailChan, KW: kwsherry@hku.hk-
dc.identifier.authorityChan, KW=rp00539-
dc.identifier.doi10.1016/S2215-0366(16)30081-5-
dc.identifier.scopuseid_2-s2.0-84971474753-
dc.identifier.hkuros285359-
dc.identifier.volume3-
dc.identifier.spage502-
dc.identifier.epage503-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats